期刊文献+

新疆哈萨克族人群中扩张型心肌病与核纤层蛋白A基因变异的关系

Relationship Between Dilated Cardiomyopathy and Nuclear Lamina Protein A Gene Mutation in Kazak Ethnics at Xinjiang Area
下载PDF
导出
摘要 目的:研究新疆哈萨克族人群中扩张型心肌病(DCM)与核纤层蛋白A(LMNA)基因变异的关系。方法:对哈萨克族一个家族性扩张型心肌病(FDCM)31名成员,特发性扩张型心肌病(IDCM)160例患者(哈萨克族80例、汉族80例)分为IDCM组(哈萨克族,简称哈)、IDCM组(汉族,简称汉)及160例健康志愿者(哈萨克族80例、汉族80例)分为对照组(哈)、对照组(汉)进行LMNA基因检测。提取外周血DNA,聚合酶链反应(PCR)扩增LMNA基因的12个外显子和外显子附近的内含子,对目的基因进行测序,测序结果与CHROMAS软件和PUBMED中BLAST软件中的标准模板进行对比,并分析突变位点与哈萨克族IDCM和汉族IDCM之间的关系。结果:在哈萨克族FDCM的先证者中检测到LMNA基因7号外显子一未报道的单个碱基C插入(insC, CGG→CCG),导致精氨酸(Arg)变为脯氨酸(Pro)。在10号外显子上,检测到一个已被报道的LMNA基因多态位点rs4641(c.1362C〉T, His454His)。随后,在IDCM组(哈)和其对照组的LMNA基因检测结果中,得出LMNA基因多态位点rs4641的基因型分布(χ2=5.16,P=0.036)和等位基因频率(χ2=4.50,P=0.034)均存在统计学意义,而在IDCM组(汉)和其对照组中却差异无统计学意义。Logistic回归分析显示LMNA基因rs4641多态位点与IDCM组(哈)存在相关性[P=0.025,比值比(OR)=0.412,95%可信区间(CI):0.189-0.896]。结论:LMNA基因在新疆汉族和哈萨克族均有较高的患病率,但经统计后,发现LMNA基因rs4641多态位点与新疆地区哈萨克族DCM存在关联,可能是新疆地区DCM患者发病的易感基因多态位点。 Objective: To study the relationship between dilated cardiomyopathy and nuclear lamina protein (LMNA) gene mutation in Kazak ethnics at Xinjiang area. Methods: A Kazak familial dilated cardiomyopathy (FDCM) with 31 members was studied. In addition, 160 patients with idiopathic dilated cardiomyopathy (IDCM) with 160 healthy controls were enrolled in our study, and they were divided into 4 groups: IDCM-Kazak, IDCM-Han and Control-Kazak, Control-Han.n=80 in each group. Peripheral blood DNA were extracted, 12 exons with nearby introns of LMNA gene were detected by PCR and the ampliifed products were sequenced and compared with the standard template of CHROMAS and BLAST software to identify mutation sites. LMNA mutation in both Kazak and Han IDCM patients were investigated. Results: A novel LMNA mutation (insC, CGG→CCG) at exon 7 was identiifed in a FDCM proband, it caused an amino acid substitution as Arg to Pro, and a known LMNA polymorphism loci rs4641 (c.1362C〉T His454His) was fund at exon 10. In addition, LMNA polymorphism loci rs4641 genotype distribution (χ2=5.16,P=0.036) and allele frequency (χ2=4.50,P=0.034) were statistically different between IDCM-Kazak group and Control-Kazak group; while such differences were no statistic meaning between IDCM-Han group and Control-Han group. Logistic regression analysis indicated that LMNA polymorphism loci rs4641 was related to IDCM occurrence in Kazak ethnics (P=0.025, OR=0.412, 95% CI 0.189-0.896). Conclusion: LMNA polymorphism loci rs4641 was related to IDCM in Kazak ethnics at Xinjiang area, which might be susceptible loci for IDCM occurrence.
出处 《中国循环杂志》 CSCD 北大核心 2015年第11期1071-1075,共5页 Chinese Circulation Journal
基金 国家自然科学基金(编号:81260069)
关键词 扩张型心肌病 核纤层蛋白A基因 单核苷酸多态性 基因突变 Dilated cardiomyopathy Nuclear lamina protein A gene Single nucleotide polymorphisms Gene mutation
  • 相关文献

参考文献20

  • 1Hershberger RE, Lindenfeld J, Mestroni L, et al. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J Card Fail, 2009,15: 83-97.
  • 2陈在嘉.心血管病与基因突变 (1)家族性肥厚型心肌病和扩张型心肌病与基因突变[J].中国循环杂志,1999,14(3):130-131. 被引量:2
  • 3Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coil Cardiol, 1999, 34: 181-190.
  • 4Fatkin D, Otway R, Richmond Z. Genetics of dilated cardiomyopathy. Heart Failure Clinics, 2010, 6: 129-140.
  • 5Mogensen J, Murphy RT, Shaw T, et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coil Cardiol, 2004, 44: 2033-2040.
  • 6Dellefave L, McNally EM. The genetics of dilated cardiomyopathy. Curr Opin Cardiol, 2010,25: 198-204.
  • 7Capell BC, Collins FS. Human laminopathies: nuclei gone genetically awry. Nat Rev Genet, 2006, 7: 940-952.
  • 8Worman HJ, Fong LG, Muchir A, et al. Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest, 2009 , 119: 1825-1836.
  • 9Song K, Dub e MP, Lim J, et al. Lamin A/C mutations associated with familial and sporadic cases of dilated cardiomyopathy in Koreans. Exp Mol Med, 2007,39: 114-120.
  • 10Sylvius N, Bilinska ZT, Veinot JP, et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet, 2005,42: 639-647.

二级参考文献20

  • 1Maron BI. Casey SA. Poliac LC. et al , Clinical course of hypertrophiccardiomyopathy in a regional united slates cohort. lAMA. 1999.281:650-655.
  • 2Olsson MC. Palmer BM. Stauffer BL, et al. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Cire res. 2004. 94:201-207.
  • 3Bai F. Wei. A. Takeda AK. et al, Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations. Biophys J, 2011,100:1014-1023.
  • 4Fraysse B, Weinberger F, Bardswell SC, et al, Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol, 2012, 52:1299-1307.
  • 5Cecchi F, Sgalambro A, Baldi M, et al. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with bypertrophic cardiomyopathy. J Cardiovasc Transl Res, 2009, 2:452-461.
  • 6Moreo A, Ambrosio G, Chiara BD, et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging, 2009,2:437-443.
  • 7Ellims AH, lies LM, Ling LH, et al.Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.J Cardiovasc Magn Reson, 2012, 14:76.
  • 8Nishimura RA, Appleton CP, Redfield MM, et al. Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous doppler echocardiographic and cardiac catheterization study. J Am Coil Cardiol, 1996,28:1226-1233.
  • 9Kitaoka H, Kubo T, Okawa M, et al. Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: comparison with B-type natriuretic peptide. J Cardiol, 2009, 53:361-367.
  • 10Arteaga E, Araujo AQ, Buck P, et al. Plasma amino-terminal pro-B?type natriuretic peptide quantification in hypertrophic cardiomyopathy. American Heart Journal, 2005,150:1228-1232.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部